Jianjun Zhao

7.2k citations
105 papers · 5.3k indexed · 2 hit papers · h-index 30

Jianjun Zhao

100 papers receiving 5.2k citations

Hit Papers

MicroRNA Expression Profiling in Human Ovarian Cancer: mi...8812008202620142020250500750

Peers

Jianjun Zhao
Comparison fields: 5 of 141
  • Cancer Research 2.5k
  • Molecular Biology 3.5k
  • Biological Psychiatry 68
  • Oncology 724
  • Dermatology 176
Replace Xiufen Zheng with:
Xiufen Zheng Canada
Tong Chen China
Junjie Zhao China
Dooil Jeoung South Korea
Gang Li China
Andreas Weigert Germany
Min Shi China
Gaoliang Ouyang China
Xinbing Sui China
Rui Zhang China
Jianjun Zhao relative to Xiufen Zheng Canada Xiufen Zheng's profile →
Citations per field
00.5×1.5×2.1×
Xiufen Zheng · 1×
Citations per year

Countries citing papers authored by Jianjun Zhao

Since Specialization
Citations

This map shows the geographic impact of Jianjun Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Zhao more than expected).

Fields of papers citing papers by Jianjun Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Zhao. The network helps show where Jianjun Zhao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jianjun Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jianjun Zhao Line = papers co-authored together Jianjun Zhao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20242
3 20232
4 20232
5 20233
6 20221
7 202141
8 20217
9 202018
10 201870
11 20181
12 201572
13 201571
14 2014159
15 20122
16 2012214
17 200888
18 2007390
19 200713
20 200645

About Jianjun Zhao

Jianjun Zhao is a scholar working on Cancer Research, Hepatology and Oncology, having authored 105 papers that have together received 5.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Circular RNAs in diseases (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (3.5k citations) and Biological Psychiatry (68 citations). Jianjun Zhao has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Jin Q. Cheng, William Kong, Lili He, Domenico Coppola, Hua Yang, William S. Dalton, Robert M. Wenham, Patricia A. Kruk, Jiawang Wang and Santo V. Nicosia. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026